Why it spreads
The story is almost too clickable.
BPC-157 has the perfect internet peptide shape: short name, dramatic recovery claims, and a mechanism story that feels biological enough to be believable. That does not make the human evidence mature.
Evidence read
Preclinical signal is not the same as clinical proof.
Animal and mechanistic studies can be useful, but they do not answer the practical human questions people usually ask: who benefits, how much, under what medical context, and with what risks.
PeptideFactCheck stance
Curiosity stays. Fake certainty goes.
BPC-157 deserves a serious profile because people are searching for it. The serious version keeps the repair biology in view while refusing to turn forum confidence into medical certainty.
Editorial boundary
What this page will not do
It will not provide dosing, cycling, sourcing, injection, or personal medical instructions. The job is to classify claims and explain mechanisms.